Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-23-000352
Filing Date
2023-03-22
Accepted
2023-03-22 16:27:27
Documents
2
Group Members
ORBIMED CAPITAL GP VI LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ss1896701_sc13da.htm SC 13D/A 84896
2 JOINT FILING AGREEMENT ss1896701_ex9901.htm EX-99.1 4878
  Complete submission text file 0000947871-23-000352.txt   91313
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 505 COAST BOULEVARD SOUTH SUITE 209 LA JOLLA CA 92037
Business Address 505 COAST BOULEVARD SOUTH SUITE 209 LA JOLLA CA 92037 8589525500
CalciMedica Inc (Subject) CIK: 0001385359 (see all company filings)

IRS No.: 205993082 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94023 | Film No.: 23753254
SIC: 2834 Pharmaceutical Preparations